中国与印度临床研究资源优势对比分析

近年来，临床研究呈现全球化的趋势，由于中国和印度均具有数量庞大、相对集中的受试人群，病种丰富，入组快以及试验费用低等特点，使中印成为这一趋势转移的焦点。鉴于两国在疾病资源、基础设施、政策法规、监管环境、语言文化等方面上各有其优势，如何在未来的临床市场中加大份额，以提升中国临床研究的国际地位，首先要了解中印两国临床研究的资源现状。笔者通过计算机检索和手工检索近年来国内外相关资料，对两国的临床研究资源和实力进行了比较分析。

Comparative Analysis of the Advantages of Clinical Research in China and India

In recent years, clinical research shows the trend of globalization. Due to characteristics of the huge number and relative concentration of patients, the wide variety of diseases, a high patient enrolment rate, lower trials costs, and so on, China and India become a focus of this trend. However, China and India also have their own advantages in the aspects of diseases, infrastructure, policies, regulations, regulatory environment, language, and culture. The key question to address is： how to increase the shares in the trial market in the future and to enhance the international status of China＇s clinical research？ Before we answer this question, we must understand the present situations of clinical research resources in China and India. So, we searched the relevant literature at home and abroad by computer and hand to analyze advantages and efficiency of clinical research resources in China and India.